<?xml version="1.0" encoding="UTF-8"?>
<ref id="B77">
 <label>77</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gaziano</surname>
    <given-names>J. M.</given-names>
   </name>
   <name>
    <surname>Cincotta</surname>
    <given-names>A. H.</given-names>
   </name>
   <name>
    <surname>Vinik</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Blonde</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Bohannon</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Scranton</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects</article-title>
  <source>
   <italic toggle="yes">Journal of the American Heart Association</italic>
  </source>
  <year>2012</year>
  <volume>1</volume>
  <issue>5</issue>
  <pub-id pub-id-type="publisher-id">e002279</pub-id>
  <pub-id pub-id-type="doi">10.1161/jaha.112.002279</pub-id>
  <pub-id pub-id-type="other">2-s2.0-84877038797</pub-id>
 </element-citation>
</ref>
